Transcutaneous Spinal Cord Stimulation Enables Recovery of Walking in Children with Acute Flaccid Myelitis Go to source) ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

This systematic review and network meta-analysis found that spinal cord stimulation therapies for treatment of chronic pain in back and/or lower extremities were associated with greater improvements ...

This systematic review and network meta-analysis found that spinal cord stimulation therapies for treatment of chronic pain ...

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud ...

Julie Pilitsis and Amir Hadanny. The licensed technology aims to apply advanced data analytics and machine learning to inform and optimize spinal cord stimulation in the treatment of pain, offering ...

Researchers at Kennedy Krieger Institute report that Transcutaneous Spinal Cord Stimulation (TSS) combined with movement ...

Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...